Consider a practice like this. Marcus Ellery runs a nine-location group outside Greenville, South Carolina, doing $14.2 million in collections, and he has just received his second letter of intent in eight months. The multiple looks strong until he reads page four: a four-year earnout, a 40% equity rollover, and a personal employment agreement he cannot exit without forfeiting most of the number. His collections are excellent. His EBITDA is clean. What the buyer will not say directly is that nearly half his high-value case flow traces back to four referring physicians who have known Marcus since residency, and none of those relationships convey in an asset purchase agreement. A pattern that appears repeatedly across the data: two groups with identical financials sign very different deals, and the difference was decided long before either owner sat down at a table. If you have never checked what this looks like in your own practice, you are standing where they stood.
The offer letter arrives and you read the multiple first. Everyone does. What you should read first is the structure, because that is where the buyer tells you what they actually think of your group. When you sit down to negotiate a DSO dental acquisition, the headline number is just a summary of a judgment made weeks earlier: how much of your revenue survives you. A group collecting $14 million with a founder who personally knows every referring physician is priced very differently from a group collecting $14 million whose new patients arrive on their own. Same production. Same chairs. Entirely different risk profile. This piece is about the second group, and what the data says about how they got there.
Why does a DSO pay more for your group than the one two miles away?
Two groups, same state, same eight locations, comparable collections. One clears a materially higher multiple and keeps more cash at close. The difference is rarely clinical. Buyers operating in a $179.4 billion market are not shopping for operatories, they are shopping for cash flow that keeps arriving after your name comes off the door. Your chair count is a commodity. Your patient pipeline is not. With DSOs now holding roughly 32% of the market, acquisition teams have integrated enough groups to know precisely which ones stall in year two, and they price that memory into your offer before you ever speak. When they model your practice, they are asking one quiet question: if we changed nothing except the ownership, how much of this production shows up next quarter? Every answer they cannot independently verify becomes a discount, a holdback, or an earnout hurdle. Your job is not to argue the multiple upward. It is to remove the reasons it was set low in the first place, and that work happens in places most owners never think of as part of the deal at all.
What does patient acquisition independence actually mean at the table?
It means new patients who arrive because of the practice, not because of you. That is the entire definition, and it carries more weight than any operational metric in your data room. Dental patients now run about 432,000 AI-assisted searches every month looking for care. Those patients have no relationship with you. They never met your associate at a study club. They arrived because your practice was findable and legible at the exact moment they decided to act, and that stream is transferable. A buyer can underwrite it. Compare that to a schedule filled by the four physicians who golf with you, the church, two decades of accumulated goodwill, the reputation you carry personally. All of it is real. None of it appears on a schedule of transferred assets. When your new patient flow is personal, the buyer discounts it, because they are purchasing a business and inheriting a stranger. When your flow is structural, they are purchasing a machine. Your leverage in the negotiation is almost exactly proportional to how much of your revenue keeps running once you leave the building for good.
Is your production attached to you or to the practice?
Pull your last twelve months and sort new patients by dependency rather than by referral category. Ask which of those patients would have found the practice if you had never been born in that county. Most owners are unsettled by the ratio. The uncomfortable version of this exercise gets run by the buyer's analyst anyway, without your context and without your explanations, so you may as well run it first. Sort into three buckets:
- Personal relationships. Referring specialists, physicians, community ties, and friendships that exist because of you specifically. Highest production quality, lowest transfer value.
- Legacy goodwill. Long-standing patients and their families who stay for continuity. Durable for a while, then quietly erodes after a change of ownership.
- Structural discovery. Patients who found the practice on their own, in a search, without a name attached. The only bucket that fully conveys.
Concentration in the first bucket appears in the buyer's model as risk, and risk appears in your offer as structure: a longer employment agreement, a larger rollover, an earnout tied to numbers you no longer fully control.
What does the acquisition team see when they look you up before the first call?
They look. Every one of them looks, usually before the introductory call is even scheduled, and what they find sets the frame for everything that follows. Here is what The Dental Index national practice audit documented across more than 201,000 US practices: roughly 70% are effectively invisible to AI-driven search, average AI readiness sits below 40 out of 100, and only about 8% score above 65. Your group is almost certainly somewhere in that middle band. Now sit on the other side of the table. A buyer types your brand into the same tools your patients use and gets a thin, inconsistent, or empty answer. That is a data point about your growth engine whether or not anyone says it out loud, and it quietly confirms the story they were already leaning toward: that this practice runs on its owner. The reverse is far more useful to you. When a buyer searches and finds a clear, consistent, well-documented presence across every location, the burden of proof shifts. Now they are the ones explaining why they should not pay for it.
How much of your multiple is decided before the first meeting?
More than feels fair. By the time a corporate development team schedules a call, they have already built a preliminary view of your group and slotted it into a valuation band. Diligence rarely discovers value. Diligence confirms or destroys the view they walked in holding. This is why owners who negotiate well are not better negotiators, they are better prepared, and the preparation happened twelve to twenty-four months earlier. You cannot build patient acquisition independence during exclusivity. You can only document what already exists. So the honest question is not how to push harder in the room. It is what your group will be able to show when someone finally asks. A steady, traceable, non-personal source of new patients across every location is not a talking point you can improvise on a call. It is either in the numbers or it is not. Groups that begin this work while they still have three years of runway walk in with a completely different posture. They are not defending a valuation. They are choosing between offers, which is the only real leverage that exists anywhere in dental practice acquisition.
| Signal the buyer checks | Group with independent patient acquisition | Owner-dependent group |
|---|---|---|
| AI search visibility | Scores in the top 8% (AI readiness above 65) | Sits in the 70% invisible to AI-driven search |
| Average AI readiness score | 65+ out of 100 | Below 40 out of 100 |
| Local discovery capture | Complete location profiles earning up to 7x more clicks | Incomplete profiles ceding the 82% of searches that end in a Maps interaction |
| High-value case flow | Discovery-driven patients booking high-value treatment at 2-3x the rate | Dependent on personal trust and chairside conversion |
| Typical deal structure | More cash at close, shorter earnout, lower rollover | Extended earnout, larger rollover, longer employment agreement |
Source: The Dental Index national practice audit · 2026
Why do referral-dependent groups end up in longer earnouts?
Because an earnout is how a buyer purchases something they cannot verify. When your new patient flow depends on relationships that live in your phone, they have two options: pay full price and absorb the risk, or share the risk with you and pay over time. They will choose the second every time, and they are not being unreasonable. They are pricing uncertainty the only way they can. The practical effect on your life is substantial. A four-year earnout means four years working inside someone else's operating model, with your final compensation tied to performance you influence but no longer direct. Staffing decisions change. Fee schedules change. In a market where 33.9% of practices are actively recruiting hygienists, a single bad quarter of open chairs can move your number, and your group may be excellent and still miss. Now flip it. When your patient flow is documented, geographic, and independent of any individual, the argument for a long earnout weakens considerably. You are not asking the buyer for trust. You are removing their need for it, and that is what actually changes terms.
What does a thin discovery footprint signal about your growth story?
Every buyer wants the same thing from your growth narrative: proof it repeats in a market you have not entered yet. A thin discovery footprint undercuts that instantly. Look at the behavior underneath the numbers. About 82% of local dental searches end in a Maps interaction, and practices with complete, well-maintained location profiles see up to seven times more clicks than those without. Your locations either capture that demand or hand it to whoever ranks above them, every single day, in silence. When a buyer sees three of your nine locations barely present in local discovery, they are not thinking about profile completeness. They are thinking about de novo risk and integration cost. If you cannot make demand appear reliably in markets you already occupy, why would their model assume you can in the next five? That is the real conversation happening on their side of the table. Groups that answer it well can point to something specific: a repeatable pattern by which a new location becomes visible, fills, and produces. That is a growth story with a mechanism attached, and mechanisms are what get underwritten.
Owner dependency does not reduce the number on the front page. It reduces the certainty that you will ever see it.
Which service lines actually move your valuation?
Mix matters more than volume, and buyers know exactly which mix they are hunting. Implant cases average around $4,500 with the segment growing about 8.5% a year. Cosmetic sits near $3,800 at 6.8%. Orthodontics averages roughly $5,500 at 5.1%. Your group is valued not only on what you collect today but on whether your collections are drifting toward those lines or away from them. Here is the part that connects straight back to the negotiation: patients who arrive through AI-assisted discovery book high-value treatment at two to three times the rate of other new patients. That is not a small operational footnote. It means the same channel that proves your acquisition independence also happens to feed the case types that lift your multiple. A group with strong discovery-driven flow tends to carry a richer mix, and a richer mix supported by a transferable channel is close to the ideal profile for a corporate buyer. If your high-value production comes mostly from long-tenured patients who trust you personally, that mix reads identically on paper and prices very differently.
What happens to your leverage after the letter of intent is signed?
It drops, and it keeps dropping. Exclusivity is a one-way ratchet. From the moment you sign, you are off the market, spending real money on advisors, telling your leadership team something is happening, and watching the buyer's team surface issues that adjust terms downward. Retrades are ordinary. They are also far easier to resist when you had more than one path into the room. This is the strongest practical argument for doing the positioning work that makes a practice findable years ahead of any conversation. Leverage in this process is not rhetorical skill, it is optionality, and optionality comes from being visibly desirable to several buyers before you engage with any of them. Groups that are easy to find, easy to verify, and clearly not dependent on one person tend to get approached rather than shopped. That is a fundamentally different negotiation. You are responding to interest instead of manufacturing it. If you take one thing from this piece, take this: the best terms are almost always signed by owners who were genuinely willing to walk, and who had a concrete reason to be.
The multiple is a summary, not a decision
Owners who negotiate well stopped treating the headline number as the thing being discussed. They read the structure first, because the earnout length and rollover percentage are where a buyer states plainly how much of your revenue they believe is really yours to sell.
Diligence confirms, it does not discover
The practices that get strong terms understand that the valuation band was set before anyone shook hands. They stopped preparing for the negotiation and started preparing for the search a buyer runs quietly, weeks earlier, on their own.
Leverage is optionality, not confidence
Groups that sign the best deals were not tougher in the room. They were wanted by more than one buyer before they engaged with any of them. Being approached instead of shopped is a structural condition, and it is built long before exclusivity.
Your buyer and your patient are asking the same question
Both are trying to determine whether this practice is findable, credible, and real without a personal introduction. Owners who see those as one question rather than two stop treating visibility as an expense and start treating it as the durable part of the enterprise value.
How do you prove the growth you are promising is repeatable?
You show the gap and the mechanism for closing it. The audit put unrealised annual revenue at roughly $147,000 for the average solo practice, demand already searching in its own market that never reaches it. Multiply that across your location count and you have a figure worth putting in front of a buyer, provided you can explain how it gets captured. That framing changes the conversation in a specific way. Instead of defending historical numbers, you are showing headroom inside your existing footprint with a documented method for reaching it. Buyers underwrite headroom when it arrives with a mechanism. They ignore it when it arrives as optimism. So the evidence has to be concrete: which locations improved their visibility, what happened to new patient volume afterward, how long the lag was, and whether the pattern held when you repeated it in a second market. That is the difference between telling a buyer your group can grow and showing them the last three times it did, deliberately, without you personally making it happen. One is a claim. The other is an asset.
What if you are not selling for another five years?
Then this matters more, not less. Everything described here is simply what a strong group looks like from the outside, and the buyer's view is just an unusually honest mirror held up to your practice. A group whose patients arrive on their own is a better group to own whether or not anyone ever writes you a check for it. It is more resilient when an associate leaves. It is easier to staff, which is not trivial when a third of practices are competing for the same hygienists. It gives you room to reduce your own chair time without watching production follow you out the door. And it quietly builds the record you will need later, because the evidence a buyer wants is longitudinal by nature. You cannot manufacture three years of independent patient acquisition in the ninety days before a call. Five years of runway is not a reason to postpone this. It is the most valuable position you will ever occupy, because you get to build leverage while nobody is watching and nothing is yet at stake.
Consider what the buyer is actually pricing. Not your equipment, not your operatories, not even your collections. They are pricing how visible and how self-sustaining your group remains when you are not in the room. That is the identical judgment your patients make when they choose between you and the practice two miles away, and both judgments run through the same place: whether your positioning is clear enough for an engine to name you and a stranger to trust you. Clear positioning is what makes AI search and Google Maps ranking work at all. Invisible positioning is an invisible practice, no matter how good the dentistry is or how much you spend. Your deal terms and your schedule are two readings of the same number. Before your next conversation with a buyer, find out what they will find.